Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong

OBJECTIVES: To investigate the association between baseline use of glucose-lowering drugs and serious clinical outcome among patients with type 2 diabetes. DESIGN: Territory-wide retrospective cohort of confirmed cases of COVID-19 between January 2020 and February 2021. SETTING: All public health fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Luk, Andrea On Yan, Yip, Terry C F, Zhang, Xinge, Kong, Alice Pik Shan, Wong, Vincent Wai-Sun, Ma, Ronald Ching Wan, Wong, Grace Lai-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529616/
https://www.ncbi.nlm.nih.gov/pubmed/34670765
http://dx.doi.org/10.1136/bmjopen-2021-052310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529616/
https://www.ncbi.nlm.nih.gov/pubmed/34670765
http://dx.doi.org/10.1136/bmjopen-2021-052310

Ejemplares similares